Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Kirn David. Director active across 1 company, notably 4D Molecular Therapeutics, Inc.. Aggregated, 10 filings have been published. Split: 0 buy · 7 sells. Total volume traded: €4.1m. History available since 15 December 2022. The latest transaction was disclosed on 1 June 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
1,922 shares@ US$10.01970.4% of flowCommon StockSEC:0001193125-26-253740:0
11,653 shares@ US$14.423.5% of flowCommon StockSEC:0000950170-24-083303:0
12,930 shares@ US$14.423.9% of flowCommon StockSEC:0000950170-24-077944:0
92,001 shares@ US$27.128252.2% of flowCommon StockSEC:0000950170-24-014091:0
5,696 shares@ US$18.40792.2% of flowCommon StockSEC:0000950170-24-007477:0
28,632 shares@ US$17.268510.1% of flowCommon StockSEC:0000950170-24-002945:0
600,000 shares0Common StockSEC:0001140361-23-023022:0
17,090 shares@ US$20.93147.5% of flowCommon StockSEC:0001567619-23-003706:0
10,899 shares@ US$20.03374.6% of flowCommon StockSEC:0001567619-23-001163:0
31,433 shares@ US$23.560215.6% of flowCommon StockSEC:0001567619-22-021815:0